Key Move. Bayer Romania appoints Gerhard Waltl as lead Pharmaceutical division

Georgeta Gheorghe 11/07/2017 | 18:36

Starting with mid-June, 2017, the Pharmaceutical division of Bayer Romania has a new leadership, following the appointment of Dr. Gerhard Waltl as Country Commercial Lead.

Dr. Waltl took over this position from Mr. Panagiotis Alekos, who is now acting on a similar role in the Czech and Slovakian markets.

„It is with great pride I join the Pharmaceutical division team in Romania, as this is not only the field I have a deep expertise in, but one that is very close to Bayer’s promise of using science to create a better life. Innovation is the beating heart of our company. What drives us forward is the research and development component – creating new molecules to help people live their lives to the fullest. I am confident that we will succeed in reaching our business goals and continue being one step ahead of the modern world challenges“, stated Dr. Waltl.

A graduate of the Ludwig-Maximilian University in Munich, Waltl has over three decades of experience in the pharmaceuticals field at international level, doubled by deep competences in marketing and management for global projects, completed by an economic university degree.

Part of the Bayer team since 1983, in various positions within the company, Waltl proved his abilities in leading both global complex team as well as local enthities in several European countries. Recently, he took over tasks in the fields of compliance, data privacy and optimizing organsational set-up of regional business representation.

BR Magazine | Latest Issue

Download PDF: Business Review Magazine March (II) 2024 Issue

The March (II) 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “BAT DBS Romania Hub: A Vibrant New Office For An Employee-Centric
Georgeta Gheorghe | 27/03/2024 | 17:32
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue